JP2009514837A5 - - Google Patents

Download PDF

Info

Publication number
JP2009514837A5
JP2009514837A5 JP2008538366A JP2008538366A JP2009514837A5 JP 2009514837 A5 JP2009514837 A5 JP 2009514837A5 JP 2008538366 A JP2008538366 A JP 2008538366A JP 2008538366 A JP2008538366 A JP 2008538366A JP 2009514837 A5 JP2009514837 A5 JP 2009514837A5
Authority
JP
Japan
Prior art keywords
acceptable salt
compound
compound according
pharmacologically acceptable
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008538366A
Other languages
English (en)
Other versions
JP2009514837A (ja
Filing date
Publication date
Priority claimed from GB0522457A external-priority patent/GB0522457D0/en
Priority claimed from GB0603133A external-priority patent/GB0603133D0/en
Application filed filed Critical
Priority claimed from PCT/EP2006/068089 external-priority patent/WO2007051847A1/en
Publication of JP2009514837A publication Critical patent/JP2009514837A/ja
Publication of JP2009514837A5 publication Critical patent/JP2009514837A5/ja
Withdrawn legal-status Critical Current

Links

Claims (12)

  1. 式(I)の化合物:
    Figure 2009514837
    (I)
    (式中、Aは5−メチルピラジン−2−イル、5−メチルピリド−2−イル、5−クロロピリド−2−イル、ピリド−2−イル、5−メチルイソキサゾル−3−イル、イソキサゾル−3−イル、5−メチルチアゾール−2−イル及びピリミジン−4−イルから選択される含窒素ヘテロアリール環である)、
    又はその薬理学的に許容できる塩。
  2. フェニル環及びシクロペンタノンを有する側鎖を、アミドカルボニル炭素に結合させる炭素原子が(R)−立体配置である、請求項1記載の化合物又はその薬理学的に許容できる塩。
  3. 前記シクロペンタノン環の前記側鎖への結合部位である炭素原子が(R)−立体配置である、請求項1または2記載の化合物又はその製薬的に許容し得る塩。
  4. Aが5−メチルピラジン−2−イル、5−メチルピリド−2−イル、5−メチルイソキサゾル−3−イル又は5−メチルチアゾール−2−イルである、請求項1から3のいずれか1項記載の化合物又はその薬理学的に許容できる塩。
  5. Aが5−クロロピリド−2−イルである、請求項1から3のいずれか1項記載の化合物又はその薬理学的に許容できる塩。
  6. Aがピリド−2−イル、イソキサゾル−3−イル又はピリミジン−4−イルである、請求項1から3のいずれか1項記載の化合物又はその薬理学的に許容できる塩。
  7. 請求項1から6のいずれか1項記載の化合物又はその薬理学的に許容できる塩、及び薬理学的に許容できる担体を含んでなる医薬組成物。
  8. 高血糖又は糖尿病の予防若しくは治療に使用するための、請求項1から6のいずれか1項記載の化合物又はその薬理学的に許容できる塩。
  9. 1つ以上の他の抗高血糖薬又は抗糖尿病性薬と組み合わせて使用するための、請求項8項記載の化合物又はその薬理学的に許容できる塩。
  10. 前糖尿病性高血糖又は耐糖能異常を示すヒトの糖尿病の予防に使用するための、請求項1から6のいずれか1項記載の化合物又はその薬理学的に許容できる塩。
  11. 高血糖又は糖尿病の治療のための医薬の製造のための、請求項1から6のいずれか1項記載の化合物又はその薬理学的に許容できる塩の使用。
  12. 式(I)の化合物
    Figure 2009514837
    (I)
    又はその製薬的に許容し得る塩の製造方法であって、式(II)
    Figure 2009514837
    (II)
    の化合物又はその活性化された誘導体と、
    式(III)
    Figure 2009514837
    (III)
    の化合物又はその塩
    (式中、Aは請求項1に記載のとおりである)
    との縮合を含んでなる方法。
JP2008538366A 2005-11-03 2006-11-03 グルコキナーゼ調節物質としてのトリシクロ置換アミド Withdrawn JP2009514837A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0522457A GB0522457D0 (en) 2005-11-03 2005-11-03 Compounds
GB0603133A GB0603133D0 (en) 2006-02-16 2006-02-16 Compounds
PCT/EP2006/068089 WO2007051847A1 (en) 2005-11-03 2006-11-03 Tricyclo substituted amides as glucokinase modulators

Publications (2)

Publication Number Publication Date
JP2009514837A JP2009514837A (ja) 2009-04-09
JP2009514837A5 true JP2009514837A5 (ja) 2009-07-23

Family

ID=37757187

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008538366A Withdrawn JP2009514837A (ja) 2005-11-03 2006-11-03 グルコキナーゼ調節物質としてのトリシクロ置換アミド

Country Status (7)

Country Link
US (1) US20080293741A1 (ja)
EP (1) EP1948622A1 (ja)
JP (1) JP2009514837A (ja)
AU (1) AU2006310476A1 (ja)
BR (1) BRPI0618063A2 (ja)
CA (1) CA2626504A1 (ja)
WO (1) WO2007051847A1 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007001650A (es) 2004-08-12 2007-07-13 Prosidion Ltd Fenilacetamidas substituidas y su uso como activadores de glucocinasa.
EP1948645A1 (en) * 2005-11-03 2008-07-30 Prosidion Limited Tricyclo substituted amides
EP2046755A2 (en) 2006-07-24 2009-04-15 F. Hoffmann-Roche AG Pyrazoles as glucokinase activators
AU2007283113A1 (en) 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
TW200831081A (en) * 2006-12-25 2008-08-01 Kyorin Seiyaku Kk Glucokinase activator
BRPI0808267A2 (pt) * 2007-03-07 2014-07-22 Kyorin Phamaceutical Co., Ltd "composto representado pela formula geral (1) ou um sal farmeceuticamente aceitável do mesmo; método para o tratamento ou prevenção de diabetes ; uso do composto; composição farmacêutica e composto representado pela formula geral (3)".
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CN101896483B (zh) 2007-12-20 2013-11-20 株式会社Lg生命科学 葡糖激酶激活剂和包含其作为活性成分的药物组合物
CL2009000004A1 (es) * 2008-01-15 2010-02-19 Lilly Co Eli Forma cristalina de r-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida; composicion farmaceutica que comprende a dicha forma cristalina; y uso para el tratamiento de diabetes o hiperglicemia.
TW200942239A (en) 2008-01-18 2009-10-16 Astellas Pharma Inc Phenylacetamide derivatives
US7741327B2 (en) 2008-04-16 2010-06-22 Hoffmann-La Roche Inc. Pyrrolidinone glucokinase activators
US8258134B2 (en) 2008-04-16 2012-09-04 Hoffmann-La Roche Inc. Pyridazinone glucokinase activators
CA2722733C (en) 2008-04-28 2016-02-23 Kyorin Pharmaceutical Co., Ltd. Cyclopentylacrylamide derivative
BRPI0912802A2 (pt) 2008-05-16 2015-10-13 Takeda San Diego Inc ativadores de glicoquinase
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
UA104742C2 (uk) 2008-12-19 2014-03-11 Эли Лилли Энд Компани Похідні арилциклопропілацетаміду, застосовні як активатори глюкокінази
CA2771278A1 (en) 2009-08-26 2011-03-03 Sanofi Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
US8222416B2 (en) 2009-12-14 2012-07-17 Hoffmann-La Roche Inc. Azaindole glucokinase activators
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
US20130197229A1 (en) 2010-10-13 2013-08-01 Christopher Matthews Method of making azaindazole derivatives
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP6218736B2 (ja) * 2012-09-26 2017-10-25 興和株式会社 新規なフェニルアセトアミド化合物、及びそれを含有する医薬

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610846B1 (en) * 1999-03-29 2003-08-26 Hoffman-La Roche Inc. Heteroaromatic glucokinase activators
US6320050B1 (en) * 1999-03-29 2001-11-20 Hoffmann-La Roche Inc. Heteroaromatic glucokinase activators
JP4091600B2 (ja) * 2002-04-26 2008-05-28 エフ.ホフマン−ラ ロシュ アーゲー 置換フェニルアセトアミド及びグルコキナーゼ活性化物質としてのその使用
WO2004072066A1 (en) * 2003-02-11 2004-08-26 Prosidion Limited Tri(cyclo) substituted amide glucokinase activator compounds
PL378117A1 (pl) * 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
JP2007533722A (ja) * 2004-04-21 2007-11-22 プロシディオン・リミテッド トリ(シクロ)置換アミド化合物
MX2007001650A (es) * 2004-08-12 2007-07-13 Prosidion Ltd Fenilacetamidas substituidas y su uso como activadores de glucocinasa.
GB0418058D0 (en) * 2004-08-12 2004-09-15 Prosidion Ltd Fluorination process

Similar Documents

Publication Publication Date Title
JP2009514837A5 (ja)
JP2009514835A5 (ja)
JP2009514836A5 (ja)
RU2470016C2 (ru) Производное бипиразола
JP2008513510A5 (ja)
JP2006500370A5 (ja)
MX2008000255A (es) Activadores de urea glucocinasa.
GEP201706611B (en) Amido compounds and their use as pharmaceuticals
MY147442A (en) Imidazoquinolines as lipid kinase inhibitors
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
WO2005044192A3 (en) Triazole compounds and uses related thereto
EP2457918A3 (en) Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes
JP2006523216A5 (ja)
JP2005112864A5 (ja)
JP2009502743A5 (ja)
TW200505919A (en) DPP-IV inhibitors
MX2009004467A (es) Compuestos benzoilo amino heterociclilo como activadores de la glucoquinasa (glk).
DE602005013822D1 (de) Cycloalkylaminderivate
JP2009510064A5 (ja)
JP2006526031A5 (ja)
JP2008500378A5 (ja)
WO2010036613A8 (en) Novel cyclic benzimidazole derivatives useful anti-diabetic agents
JP2007502287A5 (ja)
MY142551A (en) Substituted diaryl heterocycles, process for their preparation and their use as medicaments
JP2008513504A5 (ja)